Erasca (NASDAQ:ERAS) executives outlined the company’s strategy to target RAS-driven cancers and previewed upcoming clinical ...

On March 10, 2026, from 12:00 p.m. -- 1:30 p.m. ET, in room Key West ABCD at the Hilton Orlando, Avidity will host an industry forum lunch titled "Biomarker Advancements in Rare Neuromuscular Disease: ...

The presentation served as a core example of the conference’s commitment to "Evidence-Based Traditional Medicine," ...

From February 26 to 27, the NPIAP 2026 Annual Conference was held in the United States, bringing together leading clinicians, ...

Late-breaking presentation at MDA to feature Phase 3 HOPE-3 results supporting Deramiocel in Duchenne muscular ...

46 th Annual TD Cowen Healthcare Conference Conference Dates: March 2-4, 2026 Presentation Date/Time: Monday, March 2, 2026; 3:50 PM EST Presentation Format: Fireside Chat ...

Clinical Trials suffer due to inherent inefficiencies in manual workflows built on fragmented systems. It's time for a ...

New prostate cancer drug showing ‘remarkable’ results during clinical trial - The new drug, known as VIR-5500, uses a ...

Climb Bio (NASDAQ:CLYM) outlined its strategy and upcoming clinical milestones during a fireside chat at Oppenheimer’s 36th Annual Healthcare Life Sciences Conference, with Chief Medical Officer Edgar ...

The 2026 Oncology Forum will convene service line executives from Leading Health Systems and select pharmacy leaders.

Align Technology marks the official Saudi launch of iTero Lumina™ intraoral scanner through clinical education, live ...

Inventiva (Euronext Paris and NASDAQ: IVA) (“Inventiva” or the “Company”), a clinical-stage biopharmaceutical company focused on the development of an oral therapie for the treatment of metabolic ...